TC Medical(SH:600763)2017-04-19 16:00Financial Performance - Operating revenue rose by 38.15% to CNY 242,658,941.54 year-on-year[6] - Net profit attributable to shareholders increased by 19.38% to CNY 42,795,280.22 compared to the same period last year[6] - Basic and diluted earnings per share both increased by 18.18% to CNY 0.13[6] - The company's net profit attributable to shareholders for Q1 2017 was RMB 42,795,280.20, a 19.38% increase from RMB 35,849,030.50 in the previous year[13] - Net profit increased to ¥45,411,432.66, a rise of 30.0% compared to ¥34,948,942.64 in the same period last year[27] - The total comprehensive income for the current period was ¥45,411,432.61, compared to ¥34,948,942.29 in the previous period, marking a growth of 30.0%[28] Cash Flow - Net cash flow from operating activities improved significantly to CNY 2,465,928.08 from a loss of CNY 43,431,894.57 in the previous year[6] - The net cash flow from operating activities for Q1 2017 was ¥57,199,969.22, compared to a negative cash flow of ¥61,377,343.24 in the same period last year, indicating a significant improvement[37] - Total cash inflow from operating activities was ¥136,116,771.14, up from ¥76,269,845.33 year-over-year, reflecting a growth of approximately 78.5%[37] - The company received cash from other operating activities amounting to ¥105,423,039.83, which is a significant increase from ¥51,986,172.16 year-over-year, representing a growth of about 103%[37] - The total cash outflow from financing activities was ¥2,335,666.62, compared to ¥4,642,450.48 in the previous year, indicating a reduction of approximately 49.8%[34] - The company had a cash inflow from financing activities of ¥6,564,333.38, contrasting with a cash outflow of ¥4,642,450.48 in the same period last year, marking a turnaround in financing activities[34] Assets and Liabilities - Total assets increased by 2.86% to CNY 1,322,780,953.64 compared to the end of the previous year[6] - Current assets totaled CNY 404,758,310.67, up from CNY 376,269,975.67, indicating an increase of about 7.93%[18] - Total liabilities decreased to CNY 369,828,676.94 from CNY 387,408,280.98, reflecting a reduction of approximately 4.06%[20] - The company's equity increased to CNY 952,952,276.70 from CNY 898,640,844.09, showing a growth of around 6.03%[20] - The total current liabilities decreased to CNY 109,828,676.94 from CNY 127,408,280.98, indicating a reduction of about 13.83%[19] Expenses - The company reported a significant increase in management expenses, which increased by 40.95%, totaling RMB 41,778,829.20, driven by higher employee compensation and depreciation costs[13] - Total operating costs amounted to ¥185,499,699.54, up 37.7% from ¥134,659,520.76 in the prior period[26] - Management expenses decreased to ¥41,778,829.24 from ¥29,641,628.56, indicating improved cost management strategies[27] Shareholder Information - The total number of shareholders reached 25,689 at the end of the reporting period[10] - The largest shareholder, Hangzhou Baoqun Industrial Group Co., Ltd., holds 33.75% of the shares[10] Government Subsidies and Non-Recurring Items - The company reported a total of CNY 144,312.36 in government subsidies related to normal business operations[8] - The company experienced a net loss from non-recurring items totaling CNY -57,930.93[8] Other Financial Metrics - The weighted average return on equity decreased by 0.03 percentage points to 5.10%[6] - The company reported a significant decrease in tax and additional fees, down 96.90% to RMB 21,993.82, attributed to the implementation of tax reforms[13] - The company recorded an investment loss of ¥296.18, a slight improvement from a loss of ¥426,089.47 in the previous period[27]